More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

It has been about a month since the last earnings report for PTC Inc. (PTC). Shares have added about 2.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...

I've upgraded PTC Inc. to a Buy at ~$179 per share after strong FQ4 2025 results, robust customer contract growth, and improved shareholder returns. PTC's focus on product lifecycle management, ...

Constant Currency ARR Growth: 8.5% year-over-year. Free Cash Flow Growth: 16% year-over-year, totaling $857 million for fiscal '25. Revenue Contribution from Kepware and ThingWorx: Approximately $200 ...

HELIX-COUTO-CONTRACTING PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is registered under the ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

A deal between Autodesk and PTC would have made good strategic sense. The industrial software space is rapidly consolidating as the creation of digital threads and loops using data generated by ...

Autodesk (NASDAQ:ADSK) is no longer considering an acquisition of Boston-based software company PTC (NASDAQ:PTC), Bloomberg News reported, citing people with knowledge of the matter. Autodesk has ...

PTC Therapeutics reported a phase 2 win for its Novartis-partnered Huntington's disease candidate. But the readout failed to convince investors, who wiped almost 20% off PTC’s share price amid doubts ...

Boston, Massachusetts-based PTC Inc. (PTC) is a software company that aids manufacturing companies in designing, operating, and managing products. Valued at a market cap of $18.8 billion, the company ...

PTC lowered its headline guidance, but revenue and earnings per share are not the best way to judge progress at the company. The company continues to grow its annual run rate of subscription contracts ...

CALGARY, ALBERTA, CANADA, December 17, 2024 /EINPresswire / -- OncoHelix, a leader in precision diagnostics, is proud to announce its partnership with Qualisure Diagnostics to offer the groundbreaking ...